You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alternative Donor

Showing 1 - 25 of 9,483
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hematopoietic Stem Cell Transplantation, Hematologic Malignancy Trial (CliniMACS®)

Not yet recruiting
  • Hematopoietic Stem Cell Transplantation
  • Hematologic Malignancy
  • CliniMACS®
  • (no location specified)
Oct 17, 2023

Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

Terminated
Has Results
  • Immunodeficiency
  • Infusion of donor lymphocytes
  • Charlotte, North Carolina
    Levine Children's Hospital, Carolinas Medical Center
Apr 20, 2022

Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia Trial in Pittsburgh (CD3/CD19 depleted leukocytes, CD45RA

Recruiting
  • Sickle Cell Anemia
  • +2 more
  • CD3/CD19 depleted leukocytes
  • +6 more
  • Pittsburgh, Pennsylvania
    Children's Hospital of Pittsburgh of UPMC
May 4, 2022

Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

Recruiting
  • Leukemia
  • Cleveland, Ohio
    University Hospitals Seidman Cancer Center, Case Comprehensive C
Jan 24, 2022

Acute-graft-versus-host Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Suzhou (Sitagliptin + Standard

Recruiting
  • Acute-graft-versus-host Disease
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • Sitagliptin + Standard Prophylaxis
  • Standard Prophylaxis
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Jan 13, 2022

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell

No longer available
  • Acute Lymphoblastic Leukemia
  • +11 more
  • CD34+ enriched, T Cell Depleted donor stem cell product
  • San Francisco, California
    University of California, San Francisco
May 25, 2021

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Maywood (Cyclophosphamide, Tacrolimus,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Maywood, Illinois
    Loyola University Medical Center
Apr 22, 2021

Breadth of Donor Options for People With Inherited Diseases

Completed
  • Primary T-cell Immunodeficiency Disorders
  • Common Variable Immunodeficiency
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Feb 20, 2020

    Acute Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndrome Trial in Guangzhou (HSCT from MSD, HSCT from MUD, HSCT from

    Completed
    • Acute Leukemia
    • +2 more
    • HSCT from MSD
    • +6 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Mar 3, 2020

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Recession, Gingival, Surgical Procedure, Unspecified, Graft Complication Trial in Ann Arbor (Surgical Blade, Mucotome, Diamond

    Not yet recruiting
    • Recession, Gingival
    • +3 more
    • Surgical Blade
    • +3 more
    • Ann Arbor, Michigan
      University of Michigan School of Dentistry
    Jul 12, 2023

    Adenovirus, Cytomegalovirus Infections, Epstein-Barr Virus Infections Trial in Pittsburgh (Specific T- Lymphocytes)

    Not yet recruiting
    • Adenovirus
    • +2 more
    • Specific T- Lymphocytes
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    Sep 8, 2023

    MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)

    Active, not recruiting
    • Myelodysplastic Syndromes
    • cyclophosphamide, fludarabine, and antithymocyte globulin
    • Seoul, Korea, Republic of
      Asan Medical Center, University of Ulsan College of Medicine
    Oct 19, 2023

    Leukemia, Lymphoma, Myelodysplasia Trial in Philadelphia (Alpha Beta T cell depletion)

    Recruiting
    • Leukemia
    • +2 more
    • Alpha Beta T cell depletion
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Oct 27, 2021

    Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)

    Not yet recruiting
    • Graft Vs Host Disease
    • +5 more
    • CliniMACS® device
    • (no location specified)
    Jul 20, 2023

    Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)

    Recruiting
    • Hematological Malignancies
    • Total Body Irradiation
    • +6 more
    • Philadelphia, Pennsylvania
      Thomas Jefferson University
    Feb 4, 2022

    Prematurity Trial in Athens (donor human milk)

    Recruiting
    • Prematurity
    • donor human milk
    • Athens, Greece
    • +1 more
    Dec 21, 2022

    GVHD, Hematological Malignancies Trial in Belgium (Mycophenolate mofetil, Sirolimus)

    Active, not recruiting
    • Graft-Versus-Host Disease
    • Hematological Malignancies
    • Antwerpen,, Antwerpen, Belgium
    • +12 more
    Mar 22, 2022

    Kidney Transplant; Complications, CMV Trial (Letermovir 480 mg once daily, Historical/Control)

    Not yet recruiting
    • Kidney Transplant; Complications
    • CMV
    • Letermovir 480 mg once daily
    • Historical/Control
    • (no location specified)
    Aug 14, 2023

    End Stage Kidney Disease, Delayed Graft Function, Kidney Transplant; Complications Trial in Australia, New Zealand (Plasma-Lyte

    Completed
    • End Stage Kidney Disease
    • +2 more
    • Plasma-Lyte 148 (approx. pH 7.4) IV Infusion
    • 0.9% SODIUM CHLORIDE 9g/L injection BP
    • Randwick, New South Wales, Australia
    • +17 more
    Dec 12, 2022

    Premature Luteinisation, Progesterone Elevation Trial (GnRH antagonist)

    Not yet recruiting
    • Premature Luteinisation
    • Progesterone Elevation
    • GnRH antagonist
    • (no location specified)
    Mar 8, 2023

    Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (haploidentical stem cell transplant,

    Recruiting
    • Sickle Cell Disease
    • haploidentical stem cell transplant
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Maternal KIR and Fetal HLA Influence Reproductive Success in

    Recruiting
    • Reproductive Issues
    • Analysis combinations of maternal KIR and HLA-C genotypes
    • Madrid, Spain
      Instituto Valenciano de Infertilidad
    Nov 30, 2022

    Infant, Newborn, Infant, Small for Gestational Age, Infant, Extremely Low Birth Weight Trial in United States (Donor Milk,

    Completed
    • Infant, Newborn
    • +2 more
    • Donor Milk
    • Preterm Formula
    • Birmingham, Alabama
    • +16 more
    Nov 9, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jan 23, 2023